Effect of the paclitaxel vehicle, Cremophor EL, on the pharmacokinetics of doxorubicin and doxorubicinol in mice
- 1 February 1996
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 73 (4) , 522-524
- https://doi.org/10.1038/bjc.1996.90
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Clinical Pharmacokinetics of PaclitaxelClinical Pharmacokinetics, 1994
- Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance.Journal of Clinical Oncology, 1994
- Effect of the nonimmunosuppressive cyclosporin analog SDZ PSC-833 on colchicine and doxorubicin biliary secretion by the rat in vivo.1994
- Classical and novel forms of multidrug resistance and the physiological functions of P-glycoproteins in mammalsPharmacology & Therapeutics, 1993
- Modulation of P-glycoprotein-mediated drug transport by alterations in lipid fluidity of rat liver canalicular membrane vesicles.Journal of Biological Chemistry, 1992
- Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance.Journal of Clinical Oncology, 1992
- Interaction of cremophor el with human plasmaInternational Journal of Biochemistry, 1991
- REVERSAL OF THE MULTIDRUG RESISTANCE PHENOTYPE WITH CREMOPHOR EL, A COMMON VEHICLE FOR WATER-INSOLUBLE VITAMINS AND DRUGS1990
- THE SOLVENTS CREMOPHOR-EL AND TWEEN-80 MODULATE DAUNORUBICIN RESISTANCE IN THE MULTIDRUG RESISTANT EHRLICH ASCITES TUMOR1990
- Improved method for the determination of 4′-epidoxorubicin and seven metabolites in plasma by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1987